Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing

Tickers: XTSX:SVA, PINX:SEOVFTags: None LONDON, ONTARIO – November 9, 2018- Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF) (FSE: PSH), a clinical-stage regenerative medicine company, announces that it has engaged FronTier Flex, an investor relations (IR) and marketing group based in Toronto,…

Sernova Establishes Comprehensive North American Investor Relations and Communications Strategy

Tickers: XTSX:SVA, PINX:SEOVFTags: None US Program to Focus on Raising Company’s Visibility Through Engagement of Solebury Trout LONDON, ONTARIO / TheNewswire / November 6, 2018 – Sernova Corp (TSXV: SVA) (OTCQB: SEOVF) (FSE: PSH), a clinical-stage regenerative medicine company, today…

Sernova (TSXV: SVA) “CGM” will be provided to patients for a clinical trial of its Cell Pouch™.

Sernova Corp., a clinical stage company developing regenerative medicine technologies for the treatment of chronic diseases including diabetes and hemophilia, announced that continuous glucose monitoring systems “CGM” (Medtronic Minimed, Northridge, CA) will be provided to patients in Sernova’s US regenerative…